Psychedelic-assisted Group Program for First Responders
This interventional feasibility study (n=32) will evaluate the impact of oral psilocybin (10mg) combined with a 12-week group-based programme tailored for firefighters.
Details
Two-group, randomised, open-label feasibility study (n=32) testing a 12-week group-based programme for firefighters with a single 10 mg oral psilocybin dosing session at Week 10 (active group) versus the same programme with a breathwork day (control).
Participants attend weekly group sessions (12 total); first and Week 10 sessions are in-person, others remote. Week 10 dosing is given as ten 1 mg capsules (PEX010/PYEX) with a clinician and facilitator on site to support participants.
Assessments occur at baseline, mid-program (Week 6), end of program (Week 12) and 6-month follow-up; primary aims focus on feasibility, implementation and effects on interpersonal functioning and resilience.